Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local erythropoietin for healing after free gingival graft
IRCT201201278830N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of erythropoietin in palatal wound and gingival recession (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Palatal epithelialization rate, Healing degree in recipient site and 1 more. Started Oct 2016; status: completed.
02
Drugs
erythropoietin
03
Conditions
palatal woundgingival recession
Beyond the preview
Go deeper on IRCT201201278830N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201201278830N1.